Terms: = Endocrine gland cancer AND USP8, FLJ34456, 9101, ENSG00000138592, KIAA0055, P40818, MGC129718, UBPY, HumORF8
73 results:
1. Relevance of mutations in protein deubiquitinases genes and
Pękul M; Szczepaniak M; Kober P; Rusetska N; Mossakowska BJ; Baluszek S; Kowalik A; Maksymowicz M; Zieliński G; Kunicki J; Witek P; Bujko M
Front Endocrinol (Lausanne); 2024; 15():1302667. PubMed ID: 38487343
[TBL] [Abstract] [Full Text] [Related]
2. Clinical Spectrum of usp8 Pathogenic Variants in Cushing's Disease.
Rebollar-Vega RG; Zuarth-Vázquez JM; Hernández-Ramírez LC
Arch Med Res; 2023 Dec; 54(8):102899. PubMed ID: 37925320
[TBL] [Abstract] [Full Text] [Related]
3. usp8 promotes gemcitabine resistance of pancreatic cancer via deubiquitinating and stabilizing Nrf2.
Cui J; Guo Y; Yin T; Gou S; Xiong J; Liang X; Lu C; Peng T
Biomed Pharmacother; 2023 Oct; 166():115359. PubMed ID: 37639742
[TBL] [Abstract] [Full Text] [Related]
4. The clinicopathological features and prognosis of silent corticotroph tumors: an updated systematic review and meta-analysis.
Vuong HG; Dunn IF
Endocrine; 2023 Dec; 82(3):527-535. PubMed ID: 37462809
[TBL] [Abstract] [Full Text] [Related]
5. The expression of glucocorticoid and mineralocorticoid receptors in pituitary tumors causing Cushing's disease and silent corticotroph tumors.
Kober P; Rusetska N; Mossakowska BJ; Maksymowicz M; Pękul M; Zieliński G; Styk A; Kunicki J; Działach Ł; Witek P; Bujko M
Front Endocrinol (Lausanne); 2023; 14():1124646. PubMed ID: 37065760
[TBL] [Abstract] [Full Text] [Related]
6. Patterns of care and outcomes of risk reducing surgery in women with pathogenic variants in non-BRCA and Lynch syndrome ovarian cancer susceptibility genes.
Schwartz ZP; Li AJ; Walsh CS; Rimel BJ; Alvarado MM; Lentz SE; Cass I
Gynecol Oncol; 2023 Jun; 173():1-7. PubMed ID: 37030072
[TBL] [Abstract] [Full Text] [Related]
7. Pituitary tumours: molecular and genetic aspects.
De Sousa SMC; Lenders NF; Lamb LS; Inder WJ; McCormack A
J Endocrinol; 2023 Jun; 257(3):. PubMed ID: 36951812
[TBL] [Abstract] [Full Text] [Related]
8. Genetically engineered human pituitary corticotroph tumor organoids exhibit divergent responses to glucocorticoid receptor modulators.
Mallick S; Chakrabarti J; Eschbacher J; Moraitis AG; Greenstein AE; Churko J; Pond KW; Livolsi A; Thorne CA; Little AS; Yuen KCJ; Zavros Y
Transl Res; 2023 Jun; 256():56-72. PubMed ID: 36640905
[TBL] [Abstract] [Full Text] [Related]
9. The hallmarks of cancer… in pituitary tumors?
Marrero-Rodríguez D; Taniguchi-Ponciano K; Kerbel J; Cano-Zaragoza A; Remba-Shapiro I; Silva-Román G; Vela-Patiño S; Andonegui-Elguera S; Valenzuela-Perez A; Mercado M
Rev Endocr Metab Disord; 2023 Apr; 24(2):177-190. PubMed ID: 36586070
[TBL] [Abstract] [Full Text] [Related]
10. Ubiquitin-specific Protease 8 Gene Expression in Sporadic Pituitary Adenomas.
Hatipoglu E; Gunaldi O; Erkan B; Avcikurt A; Mert M; Niyazoglu M
Neuro Endocrinol Lett; 2022 Jun; 43(2):129-133. PubMed ID: 35981231
[TBL] [Abstract] [Full Text] [Related]
11. Genetic Basis of ACTH-Secreting Adenomas.
Locantore P; Paragliola RM; Cera G; Novizio R; Maggio E; Ramunno V; Corsello A; Corsello SM
Int J Mol Sci; 2022 Jun; 23(12):. PubMed ID: 35743266
[TBL] [Abstract] [Full Text] [Related]
12. Concurrent mutations of germline GPR101 and somatic usp8 in a pediatric giant pituitary ACTH adenoma: a case report.
Bao XD; Lu L; Zhu HJ; Yao Y; Feng M; Wang RZ; Zhai X; Fu Y; Gong FY; Lu ZL
BMC Endocr Disord; 2022 Jun; 22(1):152. PubMed ID: 35668434
[TBL] [Abstract] [Full Text] [Related]
13. The Genomic Landscape of Corticotroph Tumors: From Silent Adenomas to ACTH-Secreting Carcinomas.
Andonegui-Elguera S; Silva-Román G; Peña-Martínez E; Taniguchi-Ponciano K; Vela-Patiño S; Remba-Shapiro I; Gómez-Apo E; Espinosa-de-Los-Monteros AL; Portocarrero-Ortiz LA; Guinto G; Moreno-Jimenez S; Chavez-Macias L; Saucedo R; Basurto-Acevedo L; Lopez-Felix B; Gonzalez-Torres C; Gaytan-Cervantes J; Ayala-Sumuano JT; Burak-Leipuner A; Marrero-Rodríguez D; Mercado M
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35563252
[TBL] [Abstract] [Full Text] [Related]
14. Impact of RSUME Actions on Biomolecular Modifications in Physio-Pathological Processes.
Fuertes M; Elguero B; Gonilski-Pacin D; Herbstein F; Rosmino J; Ciancio Del Giudice N; Fiz M; Falcucci L; Arzt E
Front Endocrinol (Lausanne); 2022; 13():864780. PubMed ID: 35528020
[TBL] [Abstract] [Full Text] [Related]
15. Molecular genetic testing in the management of pituitary disease.
Coopmans EC; Korbonits M
Clin Endocrinol (Oxf); 2022 Oct; 97(4):424-435. PubMed ID: 35349723
[TBL] [Abstract] [Full Text] [Related]
16. Caffeic acid phenethyl ester targets ubiquitin-specific protease 8 and synergizes with cisplatin in endometrioid ovarian carcinoma cells.
Colombo D; Gatti L; Sjöstrand L; Carenini N; Costantino M; Corna E; Arrighetti N; Zuccolo M; De Cesare M; Linder S; D'Arcy P; Perego P
Biochem Pharmacol; 2022 Mar; 197():114900. PubMed ID: 34995485
[TBL] [Abstract] [Full Text] [Related]
17. Case Report: Consecutive Adrenal Cushing's Syndrome and Cushing's Disease in a Patient With Somatic
Detomas M; Altieri B; Schlötelburg W; Appenzeller S; Schlaffer S; Coras R; Schirbel A; Wild V; Kroiss M; Sbiera S; Fassnacht M; Deutschbein T
Front Endocrinol (Lausanne); 2021; 12():731579. PubMed ID: 34489873
[TBL] [Abstract] [Full Text] [Related]
18. Molecular, functional, and histopathological classification of the pituitary neuroendocrine neoplasms.
Inomoto C; Tahara S; Oyama K; Kimura M; Matsuno A; Teramoto A; Osamura RY
Brain Tumor Pathol; 2021 Jul; 38(3):183-188. PubMed ID: 34269950
[TBL] [Abstract] [Full Text] [Related]
19. usp8 inhibitor RA-9 reduces ACTH release and cell growth in tumor corticotrophs.
Treppiedi D; Di Muro G; Marra G; Barbieri AM; Mangili F; Catalano R; Serban A; Ferrante E; Locatelli M; Lania AG; Arosio M; Spada A; Peverelli E; Mantovani G
Endocr Relat Cancer; 2021 Jun; 28(8):573-582. PubMed ID: 34086599
[TBL] [Abstract] [Full Text] [Related]
20. Two Distinctive POMC Promoters Modify Gene Expression in Cushing Disease.
Araki T; Tone Y; Yamamoto M; Kameda H; Ben-Shlomo A; Yamada S; Takeshita A; Yamamoto M; Kawakami Y; Tone M; Melmed S
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3346-e3363. PubMed ID: 34061962
[TBL] [Abstract] [Full Text] [Related]
[Next]
